Frederick A. Masoudí

Learn More
Clyde W. Yancy, MD, MSc, FACC, FAHA Mariell Jessup, MD, FACC, FAHA Biykem Bozkurt, MD, PhD, FACC, FAHA Frederick A. Masoudi, MD, MSPH, FACC, FAHA Javed Butler, MBBS, FACC, FAHA Patrick E. McBride, MD, MPH, FACC Donald E. Casey, John J.V. McMurray, MD, FACC Mark H. Drazner, MD, MSc, FACC, FAHA Judith E. Mitchell, MD, FACC, FAHA Gregg C. Fonarow, MD, FACC,(More)
This document details the procedures and recommendations of the Goals and Metrics Committee of the Strategic Planning Task Force of the American Heart Association, which developed the 2020 Impact Goals for the organization. The committee was charged with defining a new concept, cardiovascular health, and determining the metrics needed to monitor it over(More)
BACKGROUND The relationship between admission glucose levels and outcomes in older diabetic and nondiabetic patients with acute myocardial infarction is not well defined. METHODS AND RESULTS We evaluated a national sample of elderly patients (n=141,680) hospitalized with acute myocardial infarction from 1994 to 1996. Admission glucose was analyzed as a(More)
Despite improvements in cardiovascular implantable electronic device (CIED) design, application of timely infection control practices, and administration of antibiotic prophylaxis at the time of device placement, CIED infections continue to occur and can be life-threatening. This has prompted the study of all aspects of CIED infections. Recognizing the(More)
BACKGROUND Acute kidney injury (AKI) is a common complication during hospitalization and is an accepted risk factor for in-hospital mortality. However, the association of severity of AKI with the long-term risk of death is not well defined. METHODS To examine the independent effect of the severity of AKI on long-term risk of death following acute(More)
BACKGROUND Insulin-sensitizing drugs of the thiazolidinedione class and metformin are commonly prescribed to treat diabetes in patients with heart failure despite strong warnings from the Food and Drug Administration against this practice. Whether this results in adverse outcomes is unknown. METHODS AND RESULTS We conducted a retrospective cohort study of(More)
BACKGROUND Medication nonadherence may reduce the effectiveness of therapies. To our knowledge, the association between medication nonadherence and mortality remains unexplored outside the context of clinical trials. METHODS A retrospective cohort study of 11 532 patients with diabetes mellitus in a managed care organization. Medication adherence was(More)
BACKGROUND Hyperglycemia on admission is associated with an increased mortality rate in patients with acute myocardial infarction. Whether metrics that incorporate multiple glucose assessments during acute myocardial infarction hospitalization are better predictors of mortality than admission glucose alone is not well defined. METHODS AND RESULTS We(More)
2010;56;254-263 J. Am. Coll. Cardiol. John S. Rumsfeld Masoudi, Charles McKay, Kathleen Hewitt, Ralph G. Brindis, Eric D. Peterson, and Gregg C. Fonarow, David Dai, Anita Y. Chen, Lloyd W. Klein, Frederick A. Matthew T. Roe, John C. Messenger, William S. Weintraub, Christopher P. Cannon, Percutaneous Coronary Intervention Treatments, Trends, and Outcomes of(More)
Michael H. Picard, MD, FASE, David Adams, RDCS, FASE, S. Michelle Bierig, RDCS, MPH, FASE, JohnM.Dent,MD,FASE, Pamela S.Douglas,MD,FASE,LindaD.Gillam,MD,FASE,AndrewM.Keller,MD,FASE, David J. Malenka, MD, FASE, Frederick A. Masoudi, MD, MSPH, Marti McCulloch, RDCS, FASE, Patricia A. Pellikka, MD, FASE, Priscilla J. Peters, RDCS, FASE, Raymond F. Stainback,(More)